Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Grint

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Diabetes Research and Clinical Practice|February 20, 2021
The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trialRovina Ruslami, Raspati C Koesoemadinata, Nanny N M Soetedjo, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
Wellcome Open Research|October 3, 2025
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)Victoria Babirye Tumusiime, Eugene Ruzagira, Claire Norcross, et al.
The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation studyFiona V Cresswell, Lillian Tugume, Nathan C Bahr, et al.
Open Forum Infectious Diseases|September 20, 2024
The Impact of GeneXpert Cerebrospinal Fluid Testing on Tuberculous Meningitis Diagnosis in Routine Care in BotswanaJames Milburn, Ookeditse Ntwayagae, Kebatshabile Ngoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in BotswanaJames Milburn, Ookeditse Ntwayagae, Rachita Suresh, et al.
Antiviral Therapy|January 6, 2018
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA studyLars Peters, Amanda Mocroft, Daniel Grint, et al.
The European Respiratory Journal|June 15, 2013
Short- and long-term mortality and causes of death in HIV/tuberculosis patients in EuropeDaria N Podlekareva, Alexander M Panteleev, Daniel Grint, et al.
Biomed Research International|April 5, 2014
TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortalityAnne Marie W Efsen, Alexander M Panteleev, Daniel Grint, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Diabetes Research and Clinical Practice|February 20, 2021
The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trialRovina Ruslami, Raspati C Koesoemadinata, Nanny N M Soetedjo, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
Wellcome Open Research|October 3, 2025
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)Victoria Babirye Tumusiime, Eugene Ruzagira, Claire Norcross, et al.
The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation studyFiona V Cresswell, Lillian Tugume, Nathan C Bahr, et al.
Open Forum Infectious Diseases|September 20, 2024
The Impact of GeneXpert Cerebrospinal Fluid Testing on Tuberculous Meningitis Diagnosis in Routine Care in BotswanaJames Milburn, Ookeditse Ntwayagae, Kebatshabile Ngoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in BotswanaJames Milburn, Ookeditse Ntwayagae, Rachita Suresh, et al.
Antiviral Therapy|January 6, 2018
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA studyLars Peters, Amanda Mocroft, Daniel Grint, et al.
The European Respiratory Journal|June 15, 2013
Short- and long-term mortality and causes of death in HIV/tuberculosis patients in EuropeDaria N Podlekareva, Alexander M Panteleev, Daniel Grint, et al.
Biomed Research International|April 5, 2014
TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortalityAnne Marie W Efsen, Alexander M Panteleev, Daniel Grint, et al.
Pageof 4